345 related articles for article (PubMed ID: 33549123)
1. Abnormal electrophysiological phenotypes and sleep deficits in a mouse model of Angelman Syndrome.
Copping NA; Silverman JL
Mol Autism; 2021 Feb; 12(1):9. PubMed ID: 33549123
[TBL] [Abstract][Full Text] [Related]
2. Sleep disturbances in Ube3a maternal-deficient mice modeling Angelman syndrome.
Colas D; Wagstaff J; Fort P; Salvert D; Sarda N
Neurobiol Dis; 2005 Nov; 20(2):471-8. PubMed ID: 15921919
[TBL] [Abstract][Full Text] [Related]
3. Strain-dependence of the Angelman Syndrome phenotypes in Ube3a maternal deficiency mice.
Born HA; Dao AT; Levine AT; Lee WL; Mehta NM; Mehra S; Weeber EJ; Anderson AE
Sci Rep; 2017 Aug; 7(1):8451. PubMed ID: 28814801
[TBL] [Abstract][Full Text] [Related]
4. Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3.
Jiang YH; Pan Y; Zhu L; Landa L; Yoo J; Spencer C; Lorenzo I; Brilliant M; Noebels J; Beaudet AL
PLoS One; 2010 Aug; 5(8):e12278. PubMed ID: 20808828
[TBL] [Abstract][Full Text] [Related]
5. Early Developmental EEG and Seizure Phenotypes in a Full Gene Deletion of Ubiquitin Protein Ligase E3A Rat Model of Angelman Syndrome.
Born HA; Martinez LA; Levine AT; Harris SE; Mehra S; Lee WL; Dindot SV; Nash KR; Silverman JL; Segal DJ; Weeber EJ; Anderson AE
eNeuro; 2021; 8(2):. PubMed ID: 33531368
[TBL] [Abstract][Full Text] [Related]
6. Translational outcomes in a full gene deletion of ubiquitin protein ligase E3A rat model of Angelman syndrome.
Berg EL; Pride MC; Petkova SP; Lee RD; Copping NA; Shen Y; Adhikari A; Fenton TA; Pedersen LR; Noakes LS; Nieman BJ; Lerch JP; Harris S; Born HA; Peters MM; Deng P; Cameron DL; Fink KD; Beitnere U; O'Geen H; Anderson AE; Dindot SV; Nash KR; Weeber EJ; Wöhr M; Ellegood J; Segal DJ; Silverman JL
Transl Psychiatry; 2020 Jan; 10(1):39. PubMed ID: 32066685
[TBL] [Abstract][Full Text] [Related]
7. Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice.
Miura K; Kishino T; Li E; Webber H; Dikkes P; Holmes GL; Wagstaff J
Neurobiol Dis; 2002 Mar; 9(2):149-59. PubMed ID: 11895368
[TBL] [Abstract][Full Text] [Related]
8. A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel
Sonzogni M; Wallaard I; Santos SS; Kingma J; du Mee D; van Woerden GM; Elgersma Y
Mol Autism; 2018; 9():47. PubMed ID: 30220990
[TBL] [Abstract][Full Text] [Related]
9. Adult
Rotaru DC; van Woerden GM; Wallaard I; Elgersma Y
J Neurosci; 2018 Sep; 38(37):8011-8030. PubMed ID: 30082419
[TBL] [Abstract][Full Text] [Related]
10. Generation of a Novel Rat Model of Angelman Syndrome with a Complete Ube3a Gene Deletion.
Dodge A; Peters MM; Greene HE; Dietrick C; Botelho R; Chung D; Willman J; Nenninger AW; Ciarlone S; Kamath SG; Houdek P; Sumová A; Anderson AE; Dindot SV; Berg EL; O'Geen H; Segal DJ; Silverman JL; Weeber EJ; Nash KR
Autism Res; 2020 Mar; 13(3):397-409. PubMed ID: 31961493
[TBL] [Abstract][Full Text] [Related]
11. Behavioral deficits in an Angelman syndrome model: effects of genetic background and age.
Huang HS; Burns AJ; Nonneman RJ; Baker LK; Riddick NV; Nikolova VD; Riday TT; Yashiro K; Philpot BD; Moy SS
Behav Brain Res; 2013 Apr; 243():79-90. PubMed ID: 23295389
[TBL] [Abstract][Full Text] [Related]
12. Hypersociability in the Angelman syndrome mouse model.
Stoppel DC; Anderson MP
Exp Neurol; 2017 Jul; 293():137-143. PubMed ID: 28411125
[TBL] [Abstract][Full Text] [Related]
13. Excessive Laughter-like Vocalizations, Microcephaly, and Translational Outcomes in the
Berg EL; Jami SA; Petkova SP; Berz A; Fenton TA; Lerch JP; Segal DJ; Gray JA; Ellegood J; Wöhr M; Silverman JL
J Neurosci; 2021 Oct; 41(42):8801-8814. PubMed ID: 34475199
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome.
Lee D; Chen W; Kaku HN; Zhuo X; Chao ES; Soriano A; Kuncheria A; Flores S; Kim JH; Rivera A; Rigo F; Jafar-Nejad P; Beaudet AL; Caudill MS; Xue M
Elife; 2023 Jan; 12():. PubMed ID: 36594817
[No Abstract] [Full Text] [Related]
15. Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome.
Sonzogni M; Zhai P; Mientjes EJ; van Woerden GM; Elgersma Y
Mol Autism; 2020 Sep; 11(1):70. PubMed ID: 32948244
[TBL] [Abstract][Full Text] [Related]
16. Flurothyl-induced seizure paradigm revealed higher seizure susceptibility in middle-aged Angelman syndrome mouse model.
Egawa K; Nakakubo S; Kimura S; Goto T; Manabe A; Shiraishi H
Brain Dev; 2021 Apr; 43(4):515-520. PubMed ID: 33408038
[TBL] [Abstract][Full Text] [Related]
17. Maternal Ube3a Loss Disrupts Sleep Homeostasis But Leaves Circadian Rhythmicity Largely Intact.
Ehlen JC; Jones KA; Pinckney L; Gray CL; Burette S; Weinberg RJ; Evans JA; Brager AJ; Zylka MJ; Paul KN; Philpot BD; DeBruyne JP
J Neurosci; 2015 Oct; 35(40):13587-98. PubMed ID: 26446213
[TBL] [Abstract][Full Text] [Related]
18. Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes.
Sonzogni M; Hakonen J; Bernabé Kleijn M; Silva-Santos S; Judson MC; Philpot BD; van Woerden GM; Elgersma Y
Mol Autism; 2019; 10():23. PubMed ID: 31143434
[TBL] [Abstract][Full Text] [Related]
19. Lovastatin suppresses hyperexcitability and seizure in Angelman syndrome model.
Chung L; Bey AL; Towers AJ; Cao X; Kim IH; Jiang YH
Neurobiol Dis; 2018 Feb; 110():12-19. PubMed ID: 29097328
[TBL] [Abstract][Full Text] [Related]
20. Ube3a imprinting impairs circadian robustness in Angelman syndrome models.
Shi SQ; Bichell TJ; Ihrie RA; Johnson CH
Curr Biol; 2015 Mar; 25(5):537-45. PubMed ID: 25660546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
